From Prescription Toward Prohibition? Mifepristone, the FDA, the States, and the Courts
About this Event
This talk will explore the role of the Food and Drug Administration (FDA) in new drug approval and restrictions to mifepristone access in the context of historical regulation, recent litigation, state abortion bans, and the current administration.
Referenced article: https://www.cambridge.org/core/journals/journal-of-law-medicine-and-ethics/article/mifepristone-paternalism-at-the-fda/80DDF0DC3471F0DC2958B6A67DEE7D58
Registration link: https://ucdenverdata.formstack.com/forms/pharm_ethics_mifepristone